Molecular testing (also called biomarker testing) looks for biological changes in genes or proteins, like EGFR or ALK, that may be associated with your cancer. In most cases, this involves testing a piece of tissue from the cancer (a biopsy).
- WHO SHOULD BE TESTED? Due to the exploding number of treatment options, we recommend all patient with non-small cell lung cancer be tested. We also offer molecular testing to those with other types of lung cancer.
- WHY IS IT IMPORTANT? Because every person's cancer is different. This testing offers you and your treatment team the information you need to identify the best treatment for your individual case.
- TREATMENT OPTIONS: Many of the changes that have been identified in genes and proteins of those with lung cancer occur in a small percentage of those impacted by the disease. There are only approved treatments for some of those changes. If there is not an approved treatment for the changes in your cancer, there may be a clinical trial that would be a good match for you. Learn more!
GET TESTED: Through LCA’s unique partnership with a leading precision medicine company, Perthera, you can begin your molecular testing journey. Get started with a one-on-one conversation with a LungMATCH specialist by calling 1-800-298-2436 or email email@example.com.